Sorteer per
Keyphrases
Pediatric
100%
IKZF1 Deletion
100%
Precursor B-cell Acute Lymphoblastic Leukemia
100%
Oncology
20%
Working Diagnosis
20%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
20%
Treatment Protocol
20%
Therapy-resistant
20%
Clinical High Risk
20%
Pediatric Acute Lymphoblastic Leukemia
20%
Acute Lymphoblastic Leukemia
20%
Dutch
20%
High Risk
20%
Overall Survival Rate
20%
Risk Stratification
20%
Copy number
20%
Genomic Profiling
20%
Group Treatment
20%
Copy number Variation
20%
Nonsense mutation
20%
Relapse-free Survival
20%
IKZF1
20%
High-resolution
20%
Most Common Cause
20%
Progenitor Cells
20%
Delayed Diagnosis
20%
PAX5
20%
EBF1
20%
Prognostic Impact
20%
DNA Copy number
20%
Future Risk
20%
Deletion mutation
20%
Relapse Rate
20%
Separation Analysis
20%
Recurrent Lesions
20%
Strong Predictor
20%
Prone Therapy
20%
Relapse Predictors
20%
Treatment Failure
20%
Medicine and Dentistry
Pediatrics
100%
Acute Lymphoblastic Leukemia
100%
Precursor
100%
Oncology
25%
Survival Rate
25%
Overall Survival
25%
Risk Stratification
25%
Group Therapy
25%
Progenitor Cell
25%
Dexamethasone
25%
Gene Dosage
25%
Recurrence Free Survival
25%
Nonsense Mutation
25%
Recurrence Risk
25%
Immunology and Microbiology
Precursor
100%
Dexamethasone
50%
Survival Rate
50%
Overall Survival
50%
Gene Dosage
50%
Nonsense Mutation
50%
Recurrence Free Survival
50%
Biochemistry, Genetics and Molecular Biology
Precursor
100%
IKZF1
100%
Overall Survival
16%
Progenitor Cell
16%
Nonsense Mutation
16%
Survival Rate
16%
EBF1
16%
PAX5
16%
Gene Dosage
16%
Recurrence Free Survival
16%
Genomics
16%
Dexamethasone
16%